AstraZeneca pledges to overcome setbacks

Drugs giant AstraZeneca attempted to win back investor confidence today as it posted higher profits and promised further growth in years to come.

Drugs giant AstraZeneca attempted to win back investor confidence today as it posted higher profits and promised further growth in years to come.

The group – under pressure following a string of setbacks involving its leading products – posted a 14% rise in 2004 sales to $21.4bn (€16.4bn). Profits lifted 16% to $4.87bn (€3.7bn) while the figure for the fourth quarter was up 55% at $1.34bn (€1bn).

You have reached your article limit. Already a subscriber? Sign in

BLACK FRIDAY

Offer ends in:

Days
0
Hours
0
Minutes
0
Seconds
0
Black Friday subscription offer

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited